Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid

Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid

Abstract Background Determination of β-amyloid (Aβ) positivity and likelihood of underlying Alzheimer’s disease (AD) relies on dichotomous biomarker cut-off values. Individuals with mild cognitive impairment (MCI) and Aβ within the normal range may still have a substantial risk of developing dementi...

Full description

Bibliographic Details
Main Authors: Anna Rosenberg, Alina Solomon, Vesna Jelic, Göran Hagman, Nenad Bogdanovic, Miia Kivipelto
Format: Article
Language:English
Published: BMC 2019-12-01
Series:Alzheimer’s Research & Therapy
Subjects:
Mild cognitive impairment
Alzheimer’s disease
Dementia
Disease progression
Prognosis
Biomarkers
Online Access:https://doi.org/10.1186/s13195-019-0557-1

Internet

https://doi.org/10.1186/s13195-019-0557-1

Similar Items